Wilson & Boucher Capital Management LLC Sells 21 Shares of McKesson Co. (NYSE:MCK)

Wilson & Boucher Capital Management LLC reduced its position in McKesson Co. (NYSE:MCK) by 2.3% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 882 shares of the company’s stock after selling 21 shares during the period. Wilson & Boucher Capital Management LLC’s holdings in McKesson were worth $436,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in MCK. ORG Partners LLC raised its stake in McKesson by 36.9% in the 2nd quarter. ORG Partners LLC now owns 371 shares of the company’s stock valued at $218,000 after acquiring an additional 100 shares during the period. DeDora Capital Inc. increased its position in shares of McKesson by 6.5% during the second quarter. DeDora Capital Inc. now owns 1,030 shares of the company’s stock valued at $602,000 after buying an additional 63 shares during the period. Founders Capital Management LLC increased its position in shares of McKesson by 11.8% during the second quarter. Founders Capital Management LLC now owns 1,137 shares of the company’s stock valued at $664,000 after buying an additional 120 shares during the period. Narus Financial Partners LLC bought a new stake in shares of McKesson during the second quarter valued at about $210,000. Finally, Miracle Mile Advisors LLC increased its position in shares of McKesson by 55.8% during the second quarter. Miracle Mile Advisors LLC now owns 874 shares of the company’s stock valued at $510,000 after buying an additional 313 shares during the period. 85.07% of the stock is currently owned by institutional investors.

McKesson Price Performance

Shares of MCK opened at $584.07 on Wednesday. The firm has a market cap of $74.14 billion, a P/E ratio of 30.25, a P/E/G ratio of 1.30 and a beta of 0.49. The stock has a 50 day simple moving average of $556.78 and a two-hundred day simple moving average of $562.15. McKesson Co. has a 1 year low of $431.35 and a 1 year high of $637.51.

McKesson (NYSE:MCK) last released its quarterly earnings data on Wednesday, November 6th. The company reported $7.07 earnings per share for the quarter, beating analysts’ consensus estimates of $6.88 by $0.19. The firm had revenue of $93.65 billion during the quarter, compared to analyst estimates of $89.33 billion. McKesson had a negative return on equity of 207.50% and a net margin of 0.77%. The business’s quarterly revenue was up 21.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $6.23 earnings per share. On average, equities analysts anticipate that McKesson Co. will post 32.73 earnings per share for the current year.

McKesson Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, January 2nd. Stockholders of record on Monday, December 2nd will be paid a dividend of $0.71 per share. This represents a $2.84 dividend on an annualized basis and a dividend yield of 0.49%. The ex-dividend date of this dividend is Monday, December 2nd. McKesson’s dividend payout ratio (DPR) is presently 14.71%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the company. Deutsche Bank Aktiengesellschaft decreased their price target on McKesson from $623.00 to $579.00 and set a “buy” rating on the stock in a research report on Wednesday, September 25th. Leerink Partners decreased their price target on McKesson from $665.00 to $630.00 and set an “outperform” rating on the stock in a research report on Monday, October 7th. Baird R W upgraded McKesson from a “hold” rating to a “strong-buy” rating in a research report on Thursday, November 7th. Citigroup upped their price target on McKesson from $630.00 to $713.00 and gave the company a “buy” rating in a research report on Wednesday, November 13th. Finally, JPMorgan Chase & Co. upped their price objective on shares of McKesson from $656.00 to $661.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 21st. Two analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $635.86.

Insider Activity

In other news, EVP Leann B. Smith sold 579 shares of the stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $602.81, for a total transaction of $349,026.99. Following the completion of the sale, the executive vice president now owns 1,443 shares of the company’s stock, valued at approximately $869,854.83. This represents a 28.64 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.11% of the company’s stock.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.